Ortin Global Quarterly Results for Trading Insights
ORTINGLOBE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QMarch 2025
Ortin Global Quarterly Results Key Highlights
- Net Profit of ₹-1 Cr in March 2025 (+0.0% vs March 2025, +87.5% vs March 2024)
- EBITDA of ₹-1 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of -258.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹-1.04 in March 2025 (+0.0% vs March 2025)
Ortin Global Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 0 | 2 | 6 | 8 | - | - |
| Net Profit (₹ Cr) | -1 | -1 | -8 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | -1 | -1 | -6 | 1 | 1 | - | - |
| EPS (₹) | -1.20 | -1.04 | -9.89 | -0.12 | -0.49 | - | - |
| Operating Margin (%) | -1617.0% | -258.0% | -310.0% | 9.0% | 5.0% | - | - |
Ortin Global Share Price Trend Around Quarterly Results
Visualize Ortin Global's 1-year price movement across quarterly results — ideal for logging trades in Ortin Global share price
chart using Tickjournal. All values in ₹.
Related Pages for Ortin Global
Additional stock information and data for ORTINGLOBE
Revenue Trend (₹ Cr)
March 2023
6
March 2024
2
March 2025
0
2026
0
Net Profit Trend (₹ Cr)
March 2023
0
March 2024
-8
March 2025
-1
2026
-1
Operating Margin Trend (%)
March 2023
9.0%
March 2024
-310.0%
March 2025
-258.0%
2026
-1617.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Ortin Global quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores